Listen. Align. Invest.

Nexpring Health

Nexpring Health is a global leader in Assisted Reproductive Technology(ART), providing consumables and equipment for in-vitro fertilization(IVF) procedures to hospitals, clinics and IVF labs across 115+ countries.

Investment year: 2024

hg medical

hg medical is a leading end-to-end contract manufacturer of high-quality implants with a particular focus on innovative systems that address lower extremities disorders

Investment year: 2023

CordenPharma

CordenPharma is a leading CDMO focused on fast-growing complex niche drug modalities with end to end capabilities from early stage development to commercial large-scale manufacturing.

Investment year: 2022

OPEN Health

OPEN Health is a global leading medical affairs and market access platform serving the pharma industry.

Investment year: 2022

Avania

Avania is one of the leading global providers of outsourced clinical trial services specifically focused on medical technology, covering the full regulatory lifecycle across a broad range of therapeutic areas.

Investment year: 2022

Demetra

Demetra is a world-leading player in the bone cement and biomaterials space, serving all the major players in the orthopaedic industry.

Investment year: 2021

Cytel

Cytel is widely recognized as the industry pioneer of adaptive clinical trials technology and a thought-leader in biostatistical science.

Investment year: 2021

LGC

LGC's products form an essential part of its customers' quality assurance procedures and enable organisations to develop and commercialise new scientific products and advance research.

Investment year: 2020

Clario

Clario delivers leading endpoint technology solutions for clinical trials.

Investment year: 2020

Nemera

Nemera is a world leader in the design, development, and manufacture of drug delivery devices for the pharmaceutical, biotech, and generics industries.

Investment year: 2019

Echosens

Echosens is a specialized diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases.

Investment year: 2018

HRA Pharma

HRA is an innovative OTC pharma company with leading positions in Europe and in the US.

Investment year: 2016